Paradiem LLC lowered its stake in shares of Lam Research Corporation (NASDAQ:LRCX – Free Report) by 43.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 116,490 shares of the semiconductor company’s stock after selling 88,440 shares during the period. Lam Research accounts for about 4.8% of Paradiem LLC’s investment portfolio, making the stock its 2nd biggest holding. Paradiem LLC’s holdings in Lam Research were worth $19,941,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Clark Financial Services Group Inc. BD increased its holdings in shares of Lam Research by 4.1% in the 4th quarter. Clark Financial Services Group Inc. BD now owns 5,730 shares of the semiconductor company’s stock valued at $981,000 after acquiring an additional 226 shares during the period. Fulcrum Equity Management purchased a new stake in shares of Lam Research during the 4th quarter worth $232,000. Avior Wealth Management LLC boosted its position in Lam Research by 8.5% during the fourth quarter. Avior Wealth Management LLC now owns 2,069 shares of the semiconductor company’s stock valued at $354,000 after purchasing an additional 162 shares in the last quarter. Holos Integrated Wealth LLC bought a new stake in Lam Research during the fourth quarter valued at about $150,000. Finally, Marathon Mission Inc. grew its stake in Lam Research by 5.3% in the fourth quarter. Marathon Mission Inc. now owns 3,891 shares of the semiconductor company’s stock valued at $666,000 after purchasing an additional 197 shares during the last quarter. Institutional investors own 84.61% of the company’s stock.
Lam Research Stock Performance
LRCX opened at $233.99 on Friday. Lam Research Corporation has a 52-week low of $56.32 and a 52-week high of $256.68. The company has a quick ratio of 1.61, a current ratio of 2.26 and a debt-to-equity ratio of 0.37. The company has a market cap of $292.20 billion, a P/E ratio of 47.95, a price-to-earnings-growth ratio of 2.42 and a beta of 1.77. The firm’s 50-day moving average price is $226.72 and its 200-day moving average price is $176.12.
Lam Research (NASDAQ:LRCX – Get Free Report) last released its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 EPS for the quarter, topping analysts’ consensus estimates of $1.17 by $0.10. The company had revenue of $5.34 billion during the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. Lam Research’s revenue for the quarter was up 22.1% on a year-over-year basis. During the same period last year, the business earned $0.91 EPS. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. As a group, equities analysts anticipate that Lam Research Corporation will post 3.71 EPS for the current fiscal year.
Lam Research Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 8th. Stockholders of record on Wednesday, March 4th will be paid a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a dividend yield of 0.4%. The ex-dividend date is Wednesday, March 4th. Lam Research’s payout ratio is presently 21.31%.
Insider Activity
In other Lam Research news, insider Ava Harter sold 1,500 shares of Lam Research stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $222.66, for a total transaction of $333,990.00. Following the completion of the sale, the insider owned 53,205 shares of the company’s stock, valued at approximately $11,846,625.30. The trade was a 2.74% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Douglas R. Bettinger sold 50,057 shares of the business’s stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $224.03, for a total value of $11,214,269.71. Following the sale, the chief financial officer owned 1,081,705 shares in the company, valued at approximately $242,334,371.15. The trade was a 4.42% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 130,886 shares of company stock valued at $29,658,802 over the last ninety days. 0.31% of the stock is currently owned by insiders.
Analysts Set New Price Targets
A number of equities analysts have commented on the stock. Zacks Research upgraded shares of Lam Research from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 20th. Rothschild & Co Redburn lifted their price objective on shares of Lam Research from $225.00 to $265.00 and gave the stock a “buy” rating in a research report on Friday, February 6th. Morgan Stanley boosted their price objective on shares of Lam Research from $244.00 to $254.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 25th. Argus increased their target price on shares of Lam Research from $175.00 to $280.00 in a research report on Tuesday, February 3rd. Finally, TD Cowen raised their target price on shares of Lam Research from $170.00 to $290.00 and gave the company a “buy” rating in a research note on Thursday, January 29th. One research analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $245.35.
Check Out Our Latest Stock Analysis on LRCX
Lam Research Profile
(Free Report)
Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Lam Research, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Lam Research wasn’t on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A forward-looking investment report spotlighting the seven space companies best positioned to benefit from accelerating commercialization in 2026. It explores key industry trends, major growth catalysts, and the stocks shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools.
Featured By
345 N Reid Place, Suite 620, Sioux Falls, SD 57103
contact@marketbeat.com
(844) 978-6257
© MarketBeat Media, LLC 2010-2026. All rights reserved.
© 2026 Fair market value prices are updated every minute and are provided by Massive. Other market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer.
My Account –
